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To investigate the role of thymic myoid cells in the pathogenesis of myasthenia gravis
(MG), mRNA of nonneoplastic thymuses from eight MG patients was analyzed by dot
blot hybridization for the occurrence of acetylcholine receptor (AChR) subunit
transcripts, using the five AChR-subunit cDNAs (alpha, beta, gamma, delta, and
epsilon) as probes. Attention was particularly paid to the gamma- and epsilon-subunit
transcripts that specify fetal- or adult-type AChR. In all eight thymuses, transcripts of
the alpha-, beta-, gamma-, and delta-subunit genes were detected. Relative
autoradiographic signal intensities correlated with the frequencies of thymic myoid cells
as determined by immunostaining with anti-AChR monoclonal antibodies. In only one
of these thymuses were transcripts of the epsil,on-subunit gene detected in addition to
those of the other subunit genes. Four MG-associated thymomas without myoid cells
were devoid of any AChR-subunit mRNA. Our findings imply that fetal-type AChR is
expressed in MG thymuses as a rule, whereas adult-type AChR is coexpressed with it
only in a minority of cases. A similar pattern of cotranscription is known to occur at
certain stages of muscle development, and can be found in human rhabdomyosarcomas
with an intermediate stage of myogenesis. Because the serum autoantibodies of MG
patients exhibit preferential reactivity with fetal AChRs, the presence of fetal AChRs in
the thymus provides circumstantial evidence for an active involvement of thymic myoid
cells in the autoimmune process.
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INTRODUCTION
Myasthenia gravis (MG) is an autoimmune dis-
ease characterized by abnormally fatiguable
neuromuscular transmission caused in 90% of
patients by heterogeneous autoantibodies against
the nicotinic acetylcholine receptors (AChR) of
muscle endplates that are either reduced or func-
tionally blocked (Compston et al., 1980; Drach-
man et al., 1980; Vincent et al., 1987). Hetero-
geneous thymic alterations are another feature of
MG: thymitis--with or without lymphoid follicu-
lar hyperplasia--occurs in about 70% of patients,
and thymic atrophy and thymoma are present in
20% and 10%, respectively (Kirchner et al., 1986;
Mtiller-Hermelink et al., 1986). The relationship
*Corresponding author: Present address: Pathologisches
Institut der Universit/it, Josef Schneider Str. 2, 8700 Wiirzburg,
Germany.
between these thymic abnormalities and the
mechanisms of tolerance breakdown have not
been fully established, but seem to be different
(Compston et al., 1980; Chilosi et al., 1986).
Although there is now strong evidence that
tumor proteins with only a limited molecular
similarity to the AChR may play a causative role
in the pathogenesis of thymoma-associated MG
(Kirchner et al., 1987, 1988; Marx et al., 1989,
1990; Geuder et al., 1989; Siara et al., 1991), the
myoid cells of the thymic medulla have been sug-
gested to be involved in autosensitization in non-
thymoma-associated cases (Van de Velde et al.,
1966; Kao and Drachman, 1977; Wekerle and
Ketelsen, 1977). In fact, myoid cells were shown
to express AChR (Schluep et al., 1987; Kirchner et
al., 1988; Marx et al., 1992). However, it is contro-
versial whether these AChR are only targets of
anti-AChR autoantibodies (Schluep et al., 1987)
or whether they are also involved in the trig-
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TABLE
Summary of Results
Thymus o ]/ e yExpr.
4894/87 + + + +
31252/87 + + + +
27306/87 + + + +
10209/89 + + + +
18449/89 + + + +
6983/89 + + + + +
1574/90 + + + +
11199/90 + + + +
Identification of transcripts for the AChR alpha, beta, gamma, delta, and epsilon
subunit in MG thymuses by dot blot analysis of thymus mRNA with the respective
cDNAs probes. In Contrast to Fig. 2, only the presence absence of respective
mRNA is indicated but not relative signal intensities.
gering or maintainance of autoantibody pro-
duction (Kirchner et al., 1988).
The AChR of skeletal muscle is a pentameric
cation channel composed of four different sub-
units (Changeux and Revah, 1987; Kubalek et al.,
1987; Dipaola et al., 1989). Athough alpha, beta,
and delta subunits are indispensable parts of
fully functional AChR, the additional presence of
either the gamma or the epsilon subunit deter-
mines the fetal or adult receptor type, respect-
ively (Mishina et al., 1986). The fetal type of
AChR is not only present during development,
but is also reexpressed in adult muscles after
denervation (Witzemann et al., 1987) and is
referred to as extrajunctional AChR. Only at pre-
natal developmental stages are fetal and adult
AChRs physiologically coexpressed in appreci-
able amounts (Mishina et al., 1986). In contrast,
the adult AChR is the only detectable receptor
type in postnatal innervated muscle, where it is
confined to the endplates (Witzemann et al.,
1989; Brenner et al., 1990).
Thymic myoid cells are the only differentiated
muscle cells in adults presumed not to be physio-
logically innervated. However, whether they
express adult in addition to the demonstrated
extrajunctional type AChR (Schleup et al., 1987)
is not clear. To address this question, we have
probed thymus mRNA with the AChR alpha-,
beta-, gamma-, delta, and epsilon-subunit
cDNAs. Given the known preferential reactivity
of anti-AChR autoantibodies with extrajunctional
AChR (Weinstein and Hall, 1980; Vernet-der
Garabedian et al., 1988), our finding of tran-
scripts coding for the fetal AChR supports the
view that thymic myoid cells participate actively
in the pathogenesis of MG.
RESULTS
Human Thymuses Contain Transcripts for a
Fetal-Type AChR
As summarized in Table 1, all eight MG thy-
muses investigated exhibited transcription of the
FIGURE 1. Immunohistochemical
identification of thymic myoid cells
in the thymic medulla by the anti-
AChR monoclonal antibody
mAb155 (Tzartos et al., 1986). For
correlation with autoradiographic
intensities of dot blots (see Fig. 2),
the relative number of thymic
myoid cells was semiquantitatively
assessed (prior to mRNA extraction)
by two independent observers as
either few (not shown), some (a) or
many (b).MYOID CELLS IN MYASTHENIA GRAVIS 71
Thymus
Histology
Autoradiograph Relative Number of
Thymic Myoid Cells
LFH
Norma i
LFH
LFH
LFH
Thymoma
Thymoma
Thymoma
Thymoma
few
some
few
some
many
none
none
none
none
LFH Lymphoid Follicular Hyperplasia
FIGURE 2. Approximate corre-
lation between the relative number
of thymic myoid cells and the signal
intensities of autoradiographs of
thymus mRNA dot blots probed
with the AChR alpha-subunit
cDNA. Extraction of mRNA from
five thymuses, blotting (on the same
filter), and autoradiography were
done simultaneously and strictly in
parallel to make signal intensities
comparable.
alpha, beta, gamma, and delta AChR subunit
genes as detected by mRNA dot blotting, using
the respective AChR subunit cDNAs as probes. If
concomitantly present within a given cell, these
transcripts give rise to the expression of fetal
AChR (Mishina et al., 1986). The specificity of the
blotting procedure was checked in two ways.
First, a distinct correlation was encountered
between the frequencies of thymic myoid cells as
determined by immunohistochemistry (Fig. 1)
and the relative intensities of autoradiographs of
the respective dot blots probed with the AChR
alpha-subunit cDNA (Fig. 2). For this experi-
ment, mRNA was extracted from five thymuses
simultaneously and strictly in parallel. Second,
the specificity of hybridization was determined
by including mRNA from MG-associated’ thym-’
omas in which myoid cells were absent (Fig. 2),
or the carcinoma cell line A431 (Giard et al., 1973)
as negative controls (Fig. 3; Geuder et al., 1989,
1992). Finally, the absence of any hybridization of
the AChR gamma-subunit cDNA with mRNA
from innervated adult human skeletal muscle
(Fig. 4) confirms the specificity of our method.
A Minority of Human Thymuses Contains
Transcripts for Adult AChR
In addition to the transcripts for fetal AChR, only
one out of eight thymuses exhibited transcription
of the AChR epsilon-subunit gene (Table 1 and
Fig. 3) indicating the potential to express
adult/junctional-type AChR in addition to fetal
AChR (Mishina et al., 1986). Interestingly, this
case (#6982/89) showed a severe cortical invol-
ution after a corticosteroid treatment, which was
not performed in the other patients.
DISCUSSION
In the present investigation, we have shown that
as a rule, thymuses of MG patients contain tran-
scripts for fetal-type AChR. This finding is in72 K.I. GEUDER et al.
FIGURE 3. Cotranscription of the
AChR gamma- and epsilon subunit
gene in an MG thymus (#6983/89)
as determined by mRNA dot blots
probed with the respective cDNA.
Positivity in #6983/89 for epsilon
message is visible in the 5-/g dot
that is not overloaded as is the 10-tg
dot. For comparison, an MG thymus
is shown that has only AChR
gamma-subunit transcripts
(#11199/90). mRNA from the
human carcinoma cell line A431
served as negative control, a=10-/g,
b=5-tg mRNA.
Thymus
Thymus
A 431
a b a b
FIGURE 4. Cotranscription of all
five AChR subunit genes within a
tissue is not unique to thymic myoid
cells, but is also encountered in
human rhabdomyosarcomas (a, b),
and is physiologically present dur-
ing the perinatal period in
developing muscle (not shown; Mis-
hina et al., 1986). In contrast, adult Musclo
human muscle exhibits transcrip-
tion only of the alpha-, beta-, delta-,
and epsilon-gene coding for the AchR-subunit
adult/junctional type of AChR (c).
Rhabdomyosarcoma
Rhabdomyosareoma
keeping with plevious immunohistochemical
investigations that applied a monoclonal anti-
body specific for the human extra-junctional
AChR type (Schluep et al., 1987). In adult bovine
thymuses, the expression of fetal AChR as the
only AChR type of myoid cells was also shown
immunohistochemically by gamma- and epsilon-
subunit specific mAbs (Nelson and Conti-
Tronconi, 1990). Our additional investigations
also demonstrated transcripts exclusively of the
fetal AChR in normal thymuses containing
myoid cells (in preparation). Using dot blotting,
we did not detect transcripts of the AChR in MG-
associated thymomas without myoid cells (Fig.
2), whereas Hara et al. (1991) recently reported a
positivity by applying the PCR method.
We also show here that in a minority of human
thymuses, epsilon-subunit mRNA, which charac-
terizes the adult-type receptor, is present in
addition to the other subunit mRNAs (Fig. 3).
Whether this cotranscription correlates to a
corticosteroid pretreatment of MG patients (as in
our case) has to be proven by further studies (in
preparation). The same finding of transcription
of all five AChR subunit genes was recently
reported in a rat thymus myoid cell line
(Kobayashi et al., 1990). However, without in situ
hybridization, we cannot be certain whether the
mRNAs for all five AChR subunits occur
together in single myoid cells, or if these myoid
cells only express either fetal- or adult-type
receptor. We cannot even exclude transcription
of single AChR subunit genes in individual cells
that would not result in any functional receptor
(Mishina et al., 1986).
Adult and fetal AChR may cooccur within the
same muscle during a short pre- and postnatal
period (Mishina et al., 1986; Witzmann et al.,
1989; Brenner et al., 1990). In addition, we have
identified transcripts for both AChR types in
rhabdomyosarcomas and in nephroblastomas
that exhibit a partial rhabdomyomatous differen-
tiation (Kirchner et al., 1990). As there is presum-
ably no innervation in either tumors or thymicMYOID CELLS IN MYASTHENIA GRAVIS 73
myoid cells, innervation is evidently not the only
signal (Brenner et al., 1990) that initiates tran-
scription of the AChR epsilon-subunit gene.
The present finding of fetal-type AChR mRNA
in all MG thymuses investigated has implications
for the role of thymic myoid cells in the patho-
genesis of MG. On the one hand, thyrnic rnyoid
cells are the only differentiated muscle cells in
adults that are not innervated physiologically
and that are therefore expected to express fetal-.
type AChR. On the other hand, extra-
junctional/fetal AChRs are preferentially precipi-
tated by MG sera (Weinstein and Hall, 1980;
Verent-der Garabedian et al., 1988). We therefore
conclude that AChRs on thymic myoid cells are
not just targets of anti-AChR autoantibodies, but
are antigens that actively participate in the stimu-
lation of AChR-specific T and B cells. This might
be confirmed if the autoantibodies to fetal AChR
prove to precede those to endplate receptors dur-
ing the course of MG.
MATERIALS AND METHODS
Patients and Tissues
Eight thymuses and four thymomas (as controls)
were obtained from myasthenia gravis patients
within 15 min after surgery and snap frozen in
liquid nitrogen. Thy,mitis was classified accord-
ing to Kirchner et al. (1986) according to the
degree of lymphoid follicular hyperplasia or dif-
fuse B-cell infiltration.
The diagnosis of myasthenia gravis was based
on clinical findings, including electrophysiolog-
ical investigations and the detection of serum
anti-AChR autoantibodies (Table 2).
Methods
Imrnunohistochemistry was performed on cryo-
stat sections of snap frozen tissues applying a
three-sthge immunoperoxidase technique as
described in detail previously (Kirchner et al.,
1988). Thyrnic rnyoid cells were identified by cul-
ture supernatant of monoclonal antibody
mAb155 directed against the cytoplasmic epitope
alpha371-378 of the AChR alpha subunit (Tzartos
et al., 1986) and by a purified rnonoclonal antide-
srnin antibody (Laboserv, Giessen, FRG).
Extraction of RNA, preparation of
Poly(A)/RNA by oligo-dT chromatography, and
hybridization procedures under high stringency
followed standard protocols (Ausubel et al.,
1987). Filters were hybridized at 42C for 12 hr
and washed at 55C twice for 30 rnin each with 1
xSSC/2% SDS and then for 15 rain with 0.1x
SSC/0.2% SDS. The probes were cDNAs of the
human AChR alpha and delta subunit (Schoepfer
et al., 1988; Luther et al., 1989), the mouse AChR
beta and gamma subunit (Boulter et aI., 1985;
Patrick et al., 1987), and the rat AChR epsilon
subunit (Witzemann et al., 1990). Probes were
32p-labeled to a specific activity of 109 dpm//g
DNA using a random primer DNA labeling pro-
tocol (Boehringer, Mannheim, Germany).
TABLE 2
Clinical and Pathological Findings in the Patients Included in This Study
Case No. Age Sex
(y)
Disease Serum Disease
stage antibodies duration
(Osserman, against before
1958) AChR thymectomy
(y)
HLA-Haplotype DR Thymus
A B histology
27306/87 34 IIa ++ 2
4894/87 15 IIb -/+
31252/87 9 IIb + 0.75
31611 /87 27 IIa ++ 4
18449/89 11 IIb + 0.3
6983/89 8 III -/+ 0.5
10209/89 61 IIb 0.6
1574/90 24 IIa ++ 5
11199/90 24 IIb ++ 1.3
1/2 8/39 2/3 LFH
2/28 14/44 5 Normal
1/3 8/55 1/3 LFH
1/11 35/44 4/11 LFH
/2 8/44 3 LFH
n.k. n.k. n.k. LFH
2/24 44/60 4/5 LFH
n.k. n.k. n.k. LFH
1/3 8/17 n.k. LFH
aSerum autoantibodies: +=0.5-1; +=1-20; ++>20 nmol L.
n.k.=not known.
CThymus histology: LFH=lymphoid follicular hyperplasia.
LFH with cortical involution.74 K.I. GEUDER et al.
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